GFAP and Alexander disease: Overall, in terms of beneficial effects useful for a possible pharmacological treatment of AxD, results obtained in our cellular system can be summarized as follows: PHT can decrease GFAP expression; CBZ and CLM can decrease GFAP expression and increase folding, mediated by upregualtion of alphaB-crystallin expression (Table 3).